2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention

被引:42
作者
Grundy, Scott M. [1 ]
Stone, Neil J. [2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd,Ste Y3-110, Dallas, TX 75390 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
EZETIMIBE; THERAPY;
D O I
10.1001/jamacardio.2019.0911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This guideline was developed by the American College of Cardiology (ACC), American Heart Association (AHA), and collaborating organizations (American Association of Cardiovascular and Pulmonary Rehabilitation, American Association Academy of Physician Assistants, Association of Black Cardiologists, American College of Preventive Medicine, American Diabetes Association, American Geriatrics Society, American Pharmacists Association, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association).2 The guideline committee included cardiologists, internists, epidemiologists, medical economists, patient representatives, and pediatricians. © 2019 American Medical Association. All rights reserved.
引用
收藏
页码:589 / 591
页数:3
相关论文
共 9 条
[1]   Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J].
Bhatt, Deepak L. ;
Steg, P. Gabriel ;
Miller, Michael ;
Brinton, Eliot A. ;
Jacobson, Terry A. ;
Ketchum, Steven B. ;
Doyle, Ralph T., Jr. ;
Juliano, Rebecca A. ;
Jiao, Lixia ;
Granowitz, Craig ;
Tardif, Jean-Claude ;
Ballantyne, Christie M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :11-22
[2]   Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention [J].
Bohula, Erin A. ;
Morrow, David A. ;
Giugliano, Robert P. ;
Blazing, Michael A. ;
He, Ping ;
Park, Jeong-Gun ;
Murphy, Sabina A. ;
White, Jennifer A. ;
Kesaniemi, Y. Antero ;
Pedersen, Terje R. ;
Brady, Adrian J. ;
Mitchel, Yale ;
Cannon, Christopher P. ;
Braunwald, Eugene .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (08) :911-921
[3]   Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease [J].
Cannon, Christopher P. ;
Khan, Irfan ;
Klimchak, Alexa C. ;
Reynolds, Matthew R. ;
Sanchez, Robert J. ;
Sasiela, William J. .
JAMA CARDIOLOGY, 2017, 2 (09) :959-966
[4]   Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].
Cannon, Christopher P. ;
Blazing, Michael A. ;
Giugliano, Robert P. ;
McCagg, Amy ;
White, Jennifer A. ;
Theroux, Pierre ;
Darius, Harald ;
Lewis, Basil S. ;
Ophuis, Ton Oude ;
Jukema, J. Wouter ;
De Ferrari, Gaetano M. ;
Ruzyllo, Witold ;
De Lucca, Paul ;
Im, KyungAh ;
Bohula, Erin A. ;
Reist, Craig ;
Wiviott, Stephen D. ;
Tershakovec, Andrew M. ;
Musliner, Thomas A. ;
Braunwald, Eugene ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397
[5]  
Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003
[6]  
Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.4997/JRCPE.2017.212, 10.1056/NEJMoa1615664]
[7]   Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome [J].
Schwartz, G. G. ;
Steg, P. G. ;
Szarek, M. ;
Bhatt, D. L. ;
Bittner, V. A. ;
Diaz, R. ;
Edelberg, J. M. ;
Goodman, S. G. ;
Hanotin, C. ;
Harrington, R. A. ;
Jukema, J. W. ;
Lecorps, G. ;
Mahaffey, K. W. ;
Moryusef, A. ;
Pordy, R. ;
Quintero, K. ;
Roe, M. T. ;
Sasiela, W. J. ;
Tamby, J. -F. ;
Tricoci, P. ;
White, H. D. ;
Zeiher, A. M. ;
Aylward, Philip E. ;
Drexel, Heinz ;
Sinnaeve, Peter ;
Dilic, Mirza ;
Lopes, Renato D. ;
Gotcheva, Nina N. ;
Goodman, Shaun G. ;
Prieto, Juan-Carlos ;
Yong, Huo ;
Lopez-Jaramillo, Patricio ;
Pecin, Ivan ;
Reiner, Zeljko ;
Ostadal, Petr ;
Poulsen, Steen Hvitfeldt ;
Viigimaa, Margus ;
Nieminen, Markku S. ;
Danchin, Nicolas ;
Chumburidze, Vakhtang ;
Marx, Nikolaus ;
Liberopoulos, Evangelos ;
Montenegro Valdovinos, Pablo Carlos ;
Tse, Hung-Fat ;
Kiss, Robert Gabor ;
Xavier, Denis ;
Zahger, Doron ;
Valgimigli, Marco ;
Kimura, Takeshi ;
Kim, Hyo Soo .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22) :2097-2107
[8]   Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk) Insights From the Department of Veterans Affairs [J].
Virani, Salim S. ;
Akeroyd, Julia M. ;
Nambi, Vijay ;
Heidenreich, Paul A. ;
Morris, Pamela B. ;
Nasir, Khurram ;
Michos, Erin D. ;
Bittner, Vera A. ;
Petersen, Laura A. ;
Ballantyne, Christie M. .
CIRCULATION, 2017, 135 (25) :2572-2574
[9]  
Xu Q, 2018, DEATHS FINAL DATA 20